首页 | 本学科首页   官方微博 | 高级检索  
     

复方水蛭精胶囊治疗经皮冠状动脉成形术后再狭窄36例
引用本文:徐灵建,王文云,何忧. 复方水蛭精胶囊治疗经皮冠状动脉成形术后再狭窄36例[J]. 中国实验方剂学杂志, 2001, 7(3): 53-55
作者姓名:徐灵建  王文云  何忧
作者单位:烟台大学校医院,烟台,264005
摘    要:探索观察复方中药制剂对经皮冠状动脉成形术后再狭窄的临床疗效,复方水蛭精胶囊对患者血脂水平胆固醇(Tch)影响不明显,而对甘油三酯(TG)和低密度脂蛋白(LDL-C)影响显著,对心率变异以及心脏功能临床评价也明显优于对照组,特别是左室射血分数(LVEF)及冠状动脉病变支数有明显改善,结论:复方中药制剂在治疗PTCA术后或冠心病心血管病变方面具有很大潜力,可替代单味药作用单一,剂量不足以及长期疗效稳定性差的缺点。

关 键 词:复方水蛭精胶囊 经皮冠状动脉成形术 再狭窄 中医药疗法
文章编号:1005-9903(2001)03-0053-03
收稿时间:2000-10-30
修稿时间:2000-10-01

Treatment Outcome on Restenosis after Percutaneous Transluminal Coronary Angioplasty Experience Treated with Fufangshuizhijing Capsule
XU Ling-jian,WANG Wen-yun,HE You. Treatment Outcome on Restenosis after Percutaneous Transluminal Coronary Angioplasty Experience Treated with Fufangshuizhijing Capsule[J]. China Journal of Experimental Traditional Medical Formulae, 2001, 7(3): 53-55
Authors:XU Ling-jian  WANG Wen-yun  HE You
Affiliation:Hospital of Yantai University, Yantai, 264005
Abstract:To observate the clinical effect of Fufangshuizhijing Capsule treating restenosis after Percutaneous transluminal coronary angioplasty, the results showed significant change of TG Level and LDL-C level with Fufangshuizhijing capsule orally, but no significant change for total cholesterol level. The capsule is also better for improving HRV and heart function, especially, left ventricular ejection fraction and coronary vessels disease.
Keywords:Fufangshuizhijing Capsule   Percutaneous transluminal coronary angioplasty experience   Restenosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号